Growth Opportunities in the US Point-of-care Testing Market

Digital Health Meets Point of Care—Emergence of Mobile Molecular Diagnostics

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

The US point-of-care testing (POCT) study provides an extensive analysis for 13 segments: hematology, urinalysis, infectious disease, cardiac, HbA1c, glucose, fecal occult blood test/fecal immunochemical test (FOBT/FIT), coagulation PT/INR, coagulation APTT/ACT, cholesterol, pregnancy, drugs of abuse, and blood gas and electrolytes. Key trends and market share analyses in each of these segments provide a thorough understanding of the competitive landscape. The analysis provides predictions on the future of the POCT market segments and key areas of investment that should be in the planning books for in vitro diagnostic device (IVD) companies operating in the POCT space.

Table of Contents

1. Executive Summary
Market Snapshot
Scope and Segmentation
Top Economic Motivators of Patient-centric POCT
Trends Driving POC Convergence
Trends/Factors Impacting the POCT Market
Future Trends—3 Big Predictions Driving POC Convergence
2. Market Overview
Market Definitions
POCT Tests Progression in the US
POCT Environment—Spectrum of Patient Care Testing
Market Drivers
Market Restraints
CLIA Waiver Provides Faster Access to US POCT MDx Segment with Ability to Gain more Penetration
Guide to Reimbursement—Tips from Payer Community on POCT
Retail Clinics
Global Retail Care Market Revenue—Realistic Scenario (2015–2022)
Notable Activities
Market Size and Growth Graph
Expected Penetration of POCTs
3. Vision and Strategy—Growth Opportunities
Macro to Micro Visioning
Growth Opportunities for Technology Providers
Future of POCT
Overcoming Barriers
Key Companies to Watch—Game Changers in Molecular POCT
QuantuMDx
Ubiquitome
LucigenDx
GenePOC Diagnostics
Key Companies to Watch—Molecular Diagnostics POCT
Insilixa
Oxford Nanopore
DNA Electronics
Product Pipeline
Strategic Options for Startups in POCT
Top Predictions for the US POCT Market
4. Competitive Analysis
The POCT Vendor Landscape
Point of Care Testing Landscape
Competitive Landscape for POCT Vendors by Test Type
Competitive Landscape for POCT Vendors by Test MethodologyCompetitor Segment Ranking Matrix
POCT Diagnostics Leaderboard
5. Market Forecasts
Forecast Assumptions
Revenue Forecast
Percent Revenue Forecast by Segment
Market Share Analysis
Alere
Roche Diagnostics
Abbott Diagnostics
Siemens
Others
6. Cardiac POCT Segment
Revenue Forecast
Market Share Analysis
Alere
Roche
Siemens
Others
Product Spotlight
7. Infectious Disease POCT Segment
Market Share Analysis
Alere
Quidel
Meridien
Orasure
Others
8. Coagulation PT/INR POCT Segment
Market Share Analysis
Roche Diagnostics
Alere
Philips
Abbott Diagnostics
Others
9. Blood Gas & Electrolyte POCT Segment
Market Share Analysis
Abbott Laboratories
Radiometer
Siemens Healthcare Diagnostics
Instrumentation Laboratory
Roche
Others
10. Pregnancy POCT Segment
Market Share Analysis
Alere
Quidel
Beckman Coulter
Others
11. Hematology POCT Segment
Market Share Analysis
HemoCue
Abbott
Stanbio
Others
12. HbA1c POCT Segment
Market Share Analysis
Siemens
Alere
PTS Diagnostics
Others
13. Urinalysis POCT Segment
Market Share Analysis
Siemens
Roche
Arkray
Others
14. Drugs of Abuse POCT Segment
Market Share Analysis
Alere
Medtox
Others
15. Coagulation ACT/APTT POCT Segment
Market Share Analysis
Medtronic
Abbott
HelenaLaboratories
Accriva Diagnostics
16. Blood Glucose POCT Segment
Market Share Analysis
Roche
HemoCue
Nova Biomedical
Abbott
Others
17. Cholesterol POCT Segment
Market Share Analysis
Alere
PTS Diagnostics
Roche
18. FOBT/FIT POCT Segment
Market Share Analysis
Beckman Coulter
Alere
Enterix
Others
19. Conclusions
Partnering to Innovate—Beyond Conventional Boundaries
5 Competitive Keys for Success in POCT Space
Legal Disclaimer
20. Appendix
Market Engineering Methodology
List of Abbreviations

Infographic



List of Figures & Charts

1. Overview of Healthcare Facilities, Serbia, 2015
2. Total POCT Market: Key Market Drivers, US, 2016–2020
3. Total POCT Market: Key Market Restraints, US, 2016–2020


1. POCT Market: Percent Revenue Breakdown by Segment, US, 2016 and 2020
2. Retail Care Market: Revenue Forecast, Global, 2015–2022
3. POCT Market: Market Potential by Segment, US, 2015–2020
4. Total POCT Market: Revenue Forecast, US, 2012–2020
5. Total POCT Market: Percent Revenue Forecast by Segment, US, 2012–2020
6. Total POCT Market: Market Share Evolution, US, 2012 and 2015
7. Cardiac POCT Segment: Revenue Forecast, US, 2012–2020
8. Cardiac POCT Segment: Percent of Sales, US, 2015
9. Infectious Disease POCT Segment: Revenue Forecast, US, 2012–2020
10. Infectious Disease POCT Segment: Percent of Sales, US, 2015
11. Coagulation PT/INR POCT Segment: Revenue Forecast, US, 2012–2020
12. Coagulation PT/INR POCT Segment: Percent of Sales, US, 2015
13. Blood Gas & Electrolyte POCT Segment: Revenue Forecast, US, 2012–2020
14. Blood Gas & Electrolyte POCT Segment: Percent of Sales, US, 2015
15. Pregnancy POCT Segment: Revenue Forecast, US, 2012–2020
16. Pregnancy POCT Segment: Percent of Sales, US, 2015
17. Hematology POCT Segment: Revenue Forecast, US, 2012–2020
18. Hematology POCT Segment: Percent of Sales, US, 2015
19. HbA1c POCT Segment: Revenue Forecast, US, 2012–2020
20. HbA1c POCT Segment: Percent of Sales, US, 2015
21. Urinalysis POCT Segment: Revenue Forecast, US, 2012–2020
22. Urinalysis POCT Segment: Percent of Sales, US, 2015
23. Drugs of Abuse POCT Segment: Revenue Forecast, US, 2012–2020
24. Drugs of Abuse POCT Segment: Percent of Sales, US, 2015
25. Coagulation ACT/APTT POCT Segment: Revenue Forecast, US, 2012–2020
26. Coagulation ACT/APTT POCT Segment: Percent of Sales, US, 2015
27. Blood Glucose POCT Segment: Revenue Forecast, US, 2012–2020
28. Blood Glucose POCT Segment: Percent of Sales, US, 2015
29. Cholesterol POCT Segment: Revenue Forecast, US, 2012–2020
30. Cholesterol POCT Segment: Percent of Sales, US, 2015
31. FOBT/FIT POCT Segment: Revenue Forecast, US, 2012–2020
32. FOBT/FIT POCT Segment: Percent of Sales, US, 2015



Keyword1

Keyword2

Keyword3

Related Research

Release Date : 07-Nov-17

Region : North America

Release Date : 31-Oct-17

Region : North America

Release Date : 17-Jul-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.